Exane BNP Paribas Initiates Coverage On Clorox with Underperform Rating, Announces Price Target of $130
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has initiated coverage on Clorox (NYSE:CLX) with an Underperform rating and a price target of $130.
June 24, 2024 | 5:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Exane BNP Paribas has initiated coverage on Clorox with an Underperform rating and a price target of $130, suggesting a bearish outlook.
The Underperform rating and the price target of $130, which is below the current market price, indicate a bearish outlook from Exane BNP Paribas. This could lead to a short-term decline in Clorox's stock price as investors react to the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100